FORTAZ
|
Glaxo Wellcome Inc
|
Quote
|
TAZIDIME
|
Eli Lilly and Company
|
Quote
|
NDC00173-0378-35
|
Glaxo Wellcome Inc
|
Quote
|
NDC00002-7231-25
|
Eli Lilly and Company
|
Quote
|
FORTAZ
|
Glaxo Wellcome Inc
|
Quote
|
TAZIDIME
|
Eli Lilly and Company
|
Quote
|
NDC00173-0378-35
|
Glaxo Wellcome Inc
|
Quote
|
NDC00002-7231-25
|
Eli Lilly and Company
|
Quote
|
TAZICEF
|
Hospira, Inc.
|
Quote
|
NDC00409-5082-16
|
Hospira, Inc.
|
Quote
|
NDC25021-0127-20
|
Sagent Pharmaceuticals, Inc.
|
Quote
|
NDC44567-0235-25
|
Wg Critical Care, Llc
|
Quote
|